Patent-pending antibody allows easier tracking of treatment effectiveness
Scientists from NTU Singapore, the world’s No. 1 young university, have developed an antibody which boosts the survival chances for patients suffering from influenza and pneumonia.
Proven effective in lab tests, the antibody is now being made suitable for use in humans. The scientists are also using the new antibody to develop a diagnostic kit which can help doctors accurately track the recovery progress of flu and pneumonia patients.
The patent-pending antibody has generated much interest globally. Two biotech multi-national corporations, Abcam based in the United Kingdom and Adipogen International based in the United States, have won the rights to license the antibody. The two multinational companies will produce the antibody for sale to global organisations doing research in vaccine and drug development.
The breakthrough finding was published in the latest issue of the prestigious international peer-reviewed journal Cell Reports.
Influenza epidemics, such as the deadly 1918 Spanish Flu which killed over 50 million people or the severe acute respiratory syndrome (SARS) outbreak in 2002, are of big concern to governments and the general populace worldwide.
The World Health Organisation estimated that influenza results in about 3 to 5 million cases of severe illness worldwide each year, with about 250,000 to 500,000 deaths annually.
Pneumonia is the leading cause of death in children worldwide accounting for 15 per cent of all deaths for children under 5 years old, and is among the top 10 leading causes of death in the United States.
This new antibody was developed by NTU Singapore’s Associate Professor Andrew Tan, who led an interdisciplinary team of scientists from Singapore.
“While it will take up to eight years to develop the antibody into a useable treatment for human patients, we are currently developing a diagnostic kit which should be commercialised in about three years,” said Assoc Prof Tan.
“The kit will help doctors diagnose the severity of pneumonia and the efficacy of the prescribed treatment. This is done by detecting the concentration of a particular protein called ANGPTL4, which is present in samples taken from patients suffering from upper respiratory tract infections.”
The Latest on: Pandemics
via Google News
The Latest on: Pandemics
- Why You Don’t Need to Isolate Yourself to Survive the Next Pandemicon September 7, 2019 at 6:00 am
We know what pandemics look like in the movies: sudden-onset symptoms, rapid transmission, chaos at hospitals and ports of entry … and, pretty soon, roving bands of armed survivors looting ...
- African Public Health Foundation to Address Epidemic Preparedness and Responseon September 6, 2019 at 7:55 am
Overall, the annual global cost of moderately severe to severe pandemics is roughly $570 billion, or 0.7% of global income – a cost in the same order of magnitude as climate change.
- Influenza Diagnostics Market 2019 Global Industry Share, Size Estimation, Demand, Trend, Challenges, Comprehensive Insights, Future Forecasts To 2023on September 4, 2019 at 6:25 pm
Pandemics influenza is noted as a new flu virus strain that can quickly spread from person to person. Every year recurrent flu affects millions of people and results in thousands of hospitalizations ...
- Breakingviews - Ebola bonds are wonky way to tackle pandemicson August 13, 2019 at 7:54 am
LONDON (Reuters Breakingviews) - Ebola bonds seem like a decent idea. Marrying the good intentions of concerned governments and market incentives sounds a promising way to battle the latest outbreak ...
- How Ordinary People Can Help Save the World from Its Biggest Threats -- Climate Change, Pollution, Pandemics, Terrorism, and Waron August 6, 2019 at 5:50 am
NEW YORK, Aug. 6, 2019 /PRNewswire/ -- To be alive today is to be scared—and for good reason. Scientists, generals, politicians, doctors, environmentalists and economists warn that in the next decade ...
- How Ordinary People Can Help Save the World from Its Biggest Threats -- Climate Change, Pollution, Pandemics, Terrorism, and Waron August 6, 2019 at 5:43 am
Volunteers are being sought for the new Planned Acts of Kindness initiative before the world reaches its irreversible tipping point NEW YORK, Aug. 6, 2019 /PRNewswire/ -- To be alive today is to be ...
- Longer Looks: Preparing For Pandemics; Escaping Paradise; Lessons From Covering The Opioid Epidemic; And Moreon August 2, 2019 at 5:56 am
Each week, KHN finds interesting reads from around the Web. The New York Times: Vas Narasimhan Of Novartis: ‘We Are Not At All Prepared For A Pandemic’ Vas Narasimhan was drawn to work in public ...
- Birds poop out flu viruses that could become deadly global pandemics. These scientists swab their butts to protect us from that threat.on July 14, 2019 at 7:32 am
An image of a chain link. It symobilizes a website link url. An envelope. It indicates the ability to send an email. A stylized bird with an open mouth, tweeting. The word "in". A stylized letter F.
- Birds poop out flu viruses that could become deadly global pandemics. These scientists swab their butts to protect us from that threat.on July 14, 2019 at 5:57 am
We are not prepared for the next pandemic flu virus. If a pandemic virus were unleashed today, it could kill 30 million people in one year. Scientists have discovered a flu hotspot on the New Jersey ...
- $21.9 Million Gene Modulation Research Effort Targets Influenza Pandemicson June 28, 2019 at 1:48 pm
A multifaceted research effort aimed at temporarily modulating gene expression using RNA-based techniques could help protect against pandemic flu by boosting lung resistance to infection, attacking ...
via Bing News